High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study

por Rongyi, Chen, Xiaojuan, Dai, Jinghua, Wang, Lingying, Ma, Xiaomin, Dai, Lili, Ma, Huiyong, Chen, Lindi, Jiang, Ying, Sun
Publicado 2023

In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease

por Zongfei, Ji, Rongyi, Chen, Xiaomeng, Cui, Lili, Ma, Lingying, Ma, Xiufang, Kong, Xiaomin, Dai, Zhuojun, Zhang, Huiyong, Chen, Ying, Sun, Lindi, Jiang
Publicado 2020

Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry

por Zongfei, Ji, Lijuan, Zhang, Ying, Sun, Dongmei, Liu, Sifan, Wu, Xiufang, Kong, Lingying, Ma, Yun, Liu, Lili, Ma, Huiyong, Chen, Lindi, Jiang
Publicado 2021

Clinical and pathological predictors of relapse in IgG4-related disease

por Zongfei, Ji, Lingli, Chen, Ying, Sun, Lingying, Ma, Lijuan, Zhang, Dongmei, Liu, Xiaomin, Dai, Yingyong, Hou, Huiyong, Chen, Lili, Ma, Lindi, Jiang
Publicado 2022